Akums Drugs and Pharmaceuticals Limited — Others, 09-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Akums Drugs and Pharmaceuticals Limited has confirmed that there were no deviations in the utilization of funds raised through its Initial Public Offer amounting to ₹6,800 million for the quarter ended September 30, 2024. The statement was reviewed and approved by the Audit Committee, ensuring compliance with relevant guidelines. The funds have been utilized as initially outlined without any changes in allocation or usage.